In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 152305-23-2, name is (S)-4-(4-Aminobenzyl)oxazolidin-2-one, introducing its new discovery. Quality Control of (S)-4-(4-Aminobenzyl)oxazolidin-2-one
Design, synthesis, and evaluation of 4-(4?-aminobenzyl)-2-oxazolidinones as novel inhibitors of the cytochrome P-450 enzyme aromatase
The synthesis of a series of N-alkylated 4-(4?aminobenzyl)-2-oxazolidinones is described using a synthetically useful scheme which avoids the use of phosgene – since the derivatization is undertaken with the oxazolidin-2-one ring intact. The compounds were tested for human placental aromatase (AR) inhibition in vitro, using [1beta, 2beta-3H]androstenedione as substrate for the AR enzyme. The compounds were found, in general, to be more potent than the standard compound, amino-glutethimide (AG), and as such proved to be good lead compounds in the search for more specific AR inhibitors.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 152305-23-2, and how the biochemistry of the body works.Quality Control of (S)-4-(4-Aminobenzyl)oxazolidin-2-one
Reference：
Oxazolidine – Wikipedia,
Oxazolidine | C3H2224NO – PubChem